Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential

SUZHOU, China and ROCKVILLE, Md,, June 5, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released preliminary results from a Phase Ib/II study of the Bcl-2 inhibitor, lisaftoclax (APG-2575), as a monotherapy or combined … Read more

Lunit et Capio S:t Göran collaborent pour remédier à la pénurie de radiologues grâce à l’analyse mammographique assistée par IA

– Lunit et le plus grand hôpital privé de Suède lancent une nouvelle approche pour combiner l’expertise des radiologues avec l’IA SÉOUL, Corée du Sud, 6 juin 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), un important fournisseur mondial de solutions de diagnostic du cancer alimentées par l’IA, a annoncé aujourd’hui la signature d’un accord de fourniture et … Read more

Telix to Present at Jefferies Healthcare Conference

MELBOURNE, Australia, June 5, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare Conference being held in New York from June 7 to June 9, 2023. The presentation will take place on Wednesday June 7 … Read more

Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting USA – English APAC – English

ROCKVILLE, Md. and SUZHOU, China, June 5, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, and IASO Biotechnology (“IASO Bio”), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative … Read more

Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting

SUZHOU, China, June 5, 2023 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, has presented updated data of Cohort C from a phase I/IIa, multi-center study of Osemitamab (TST001) in combination with Capecitabine and Oxaliplatin (CAPOX) as a … Read more

Innovent Presents Phase 1 Clinical Data of IBI351 (KRASG12C Inhibitor) as Monotherapy for Metastatic Colorectal Cancer at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 5, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, announced the preliminary data of IBI351 (GFH925, KRASG12C inhibitor) is presented at the 2023 American … Read more

Historic Actos RICO Class Action Against Big Pharma Could be Worth Billions

LOS ANGELES, June 5, 2023 /PRNewswire/ — A federal court unsealed an order that certified a national multi-billion dollar class action against Takeda Pharmaceutical Company and Eli Lilly and Company, alleging that the companies violated the civil Racketeer Influenced and Corrupt Organizations Act (RICO) by concealing the risk of Actos and bladder cancer. The Hon. … Read more

THE SCIENCE BEHIND OUR STRESS

LEARN HOW TO ACTIVELY REDUCE STRESS THROUGH STIMULATION OF THE VAGUS NERVE ROCKAWAY, N.J., June 5, 2023 /PRNewswire/ — BACKGROUND:Ask any American if they are currently living with stress and the answer would likely be a resounding YES. Everybody agrees that stress makes life less enjoyable, and it isn’t hard to see how it might … Read more

Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS Imaging

News Summary: New resolution enhancement mode (REM) for Waters’ multi-reflecting time-of-flight (MRT) mass spectrometer leads to greater specificity and higher sample throughput for metabolomics UPLC™-MS/MS and MS imaging studies. Waters’ MRT System is the only commercially available instrument capable of 300,000 full width half maximum (FWHM) resolution, a 3X faster scan rate and parts-per-billion mass … Read more

Medline optimizes leading Remedy Skin Care line

Updated packaging, clinical educational enhancements help clinicians elevate patient care delivery NORTHFIELD, Ill., June 5, 2023 /PRNewswire/ — Medline, the market leader in skin care, today announced a re-packaging initiative for its Remedy Skin Care line as part of the company’s commitment to making skin care more intuitive for clinicians. Attendees of this year’s WOCNext … Read more